Greek for "split mind", split
between the emotional and
intellectual aspects of
experience. there are NO
DEPENDABLE LAB TESTS, only
rely on observation for diagnosis
DIAGNOSED
based on
deteriorating
functioning
for at least 6
months.
SYMPTOMS
DELUSIONS - unjustifiable
beliefs. HALLUCINATIONS -
false sensory experiences.
DISORGANISED SPEECH.
DISORGANISED
BEHAVIOUR and WEAK OR
ABSENT SIGNS OF
EMOTION
symptoms vary so much that two
people diagnosed with schizophrenia
could be nothing alike. POSITIVE
SYMPTOMS are symptoms that are
PRESENT WHEN SHOULD BE
ABSENT (hallucinations, delusions).
NEGATIVE SYMPTOMS are ones
that are ABSENT WHEN SHOULD
BE PRESENT such as emotions
COGNITIVE SYMPTOMS include
limitations of thought and
reasoning. IQ is a few points
below the rest of the population.
DIFFICULTY understanding
ABSTRACT concepts. MAIN
PROBLEM IS disordered thought
from ABNORMAL
INTERACTIONS BETWEEN THE
CORTEX, THALAMUS AND
CEREBELLUM.
SOME CONDITIONS
RESEMBLE
SCHIZOPHRENIA in their
symptoms, such as mood
disorder patients have
trouble with delusions. people
with substance abuse have
trouble with hallucinations
and people with huntington's
disease have trouble with
hallucinations, delusions
AND disordered thinking.
STATS - since the mid 1900s,
schizophrenia has been
declining in many countries, it
appears to be less severe than
it used to. occurs in ALL
ETHNIC GROUPS. MORE
COMMON IN CITIES than rural
areas. 10 TO 100 TIMES MORE
COMMON IN US AND EUROPE.
more common in men than
women. more severe in men.
people with schizo DIE YOUNGER
on average. can get ACUTE -
sudden onset or CHRONIC -
gradual onset
usually diagnosed after 20.
people who are diagnosed later
in life showed problems in
childhood such as attention
and memory deficits.
SCHIZOPHRENIA MYSTERIES - more common in
people with type 2 (adult onset) diabetes. women
with schizophrenia before birth usually give birth
to daughters, breakdown after birth, usually have
sons.
GENETICS IN SCHIZOPHRENIA
DOESN'T DEPEND ON A SINGLE GENE. TWIN
STUDIES do show a genetic basis however and
the more closely biologically related people are,
the greater risk of schizophrenia. e.g.
MONOZYGOTIC TWINS have a higher
CONCORDANCE RATE than DZ twins.
HOWEVER MZ twins only have 50%
concordance, not 100%. DZ TWINS AND
SIBLINGS have the same genetic resemblance
but DZ twins have a higher similarity (due to
environment)
ADOPTION - children with a mother with
schizophrenia have a high probability of
schizophrenia too even if adopted by
mentally healthy parents. therefore suggests
a GENETIC BASIS. HOWEVER, we cannot
be sure that the schizophrenia isn't due to
PRENATAL ENVIRONMENT, for example,
people with S will smoke, drink, use drugs,
eat unhealthily.
MORE THAN 12 GENES ASSOCIATED with
schizophrenia. such as DISC1, which controls the
generation of new neurons in the HIPPOCAMPUS.
HOWEVER, no statistically significant relationship
between schizo and any of the genes previous
studies identified.. (SANDERS et al. 2008)
A PROMINENT hypothesis is that cases of
schizophrenia arise from new mutations.
however schizophrenia is present in 1% of the
population so is there really a mutation that is
THAT common. could the mutation be in any
of several hundred genes. MORE LIKELY that
it is a DELETION of a gene, a common error in
reproduction. Schizophrenia is more common in
children of older fathers.
NEURODEVELOPMENTAL HYPOTHESIS -
schizophrenia develops due to
abnormalities in the prenatal or neonatal
(new born) development of the nervous
system. the developing brain is
vulnerable to other disturbances. brain
development could be affected by poor
nutrition, low birth weight, premature
birth, complications during delivery.
Schizophrenia has been linked to HEAD
INJURIES IN EARLY CHILDHOOD.
however could be that early symptoms
of schizophrenia increased the risk of
head injuries.
SEASON OF BIRTH EFFECT
IN S. 5-8% greater
probability of developing
schizophrenia if born in
winter. could be due to
CONDUCTING VIRAL
INFECTIONS in autumn of
being pregnant, the virus will
impair the child's crucial
stage of brain development.
BRAIN
ABNORMALITIES IN
SCHIZOPHRENIA
people with schizophrenia have less
than average grey and white matter
and larger than average ventricles
(fluid-filled spaces in the brain). the
strongest deficits were in the left
temporal and frontal areas. the
THALAMUS IS SMALLER THAN
AVERAGE. also weaker than
average connections from
dorsolateral prefrontal cortex to other
brain areas.
people with schizophrenia show deficits
of memory and attention, the same as
someone with damage to temporal or
prefrontal cortex would. cell bodies are
also smaller than normal. people with
schizophrenia have LESS THAN NORMAL
ACTIVITY IN THE LEFT HEMISPHERE.
PROBLEMS WITH STUDYING BRAIN ABNORMALITIES - people with
schizophrenia are more likely to take drugs / alcohol etc so the brain
abnormalities might result from this. not sure if brain damage in schizophrenia is
progressive (gets worse over time) or gets worse as the person ages. studies
have shown that in young people, no difference in severity compared to older
people. NEURONS might be SHRINKING but not dying.
TREATMENTS
chlorpromazine relieves the positive
symptoms of schizo. antipsychotic
drugs also alleviate symptoms. these
drugs all BLOCK DOPAMINE
SYNAPSES. the drugs that are most
effective are the most effective at
blocking dopamine receptors.
DOPAMINE HYPOTHESIS -
schizophrenia results from
excess activity at dopamine
synapses in certain brain areas.
e.g. neurons release dopamine
at a faster than average rate
and synthesise more to replace
the molecules they do not
absorb. higher dopamine
release. FOR THE DOPAMINE
HYPO - drugs such as cocaine
induces SUBSTANCE-INDUCED
PSYCHOTIC DISORDER with the
positive synptoms of
schizophrenia.
GLUTAMATE HYPOTHESIS - states that
there is DEFICIENT ACTIVITY AT
GLUTAMATE SYNAPSES, especially in
the prefrontal cortex. DOPAMINE INHIBITS
GLUTAMATE RELEASE OR GLUTAMATE
INHIBITS DOPAMINE RELEASE.
schizophrenia is associated with
lower than normal release of
glutamate and fewer than normal
receptors in the prefrontal cortex and
hippocampus. SUPPORT FOR THE
GLUTAMATE HYPOTHESIS -
Phencyclidine (PCP) 'angel dust'
inhibits the NMDA glutamate
receptors, shows intoxication and
slurred speech and in larger doses it
produces positive and negative
symptoms of schizophrenia.
EVIDENCE found when PCP
and KETAMINE are given to
preadolescents, therefore
schizophrenia and the effects
of PCP develop well after
puberty.